These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17073792)

  • 21. Generalized proteochemometric model of multiple cytochrome p450 enzymes and their inhibitors.
    Kontijevskis A; Komorowski J; Wikberg JE
    J Chem Inf Model; 2008 Sep; 48(9):1840-50. PubMed ID: 18693719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The biodiversity of microbial cytochromes P450.
    Kelly SL; Lamb DC; Jackson CJ; Warrilow AG; Kelly DE
    Adv Microb Physiol; 2003; 47():131-86. PubMed ID: 14560664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Export of cytochrome P450 105D1 to the periplasmic space of Escherichia coli.
    Kaderbhai MA; Ugochukwu CC; Kelly SL; Lamb DC
    Appl Environ Microbiol; 2001 May; 67(5):2136-8. PubMed ID: 11319092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microbial P450 enzymes in biotechnology.
    Urlacher VB; Lutz-Wahl S; Schmid RD
    Appl Microbiol Biotechnol; 2004 Apr; 64(3):317-25. PubMed ID: 14716467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A diverse family of thermostable cytochrome P450s created by recombination of stabilizing fragments.
    Li Y; Drummond DA; Sawayama AM; Snow CD; Bloom JD; Arnold FH
    Nat Biotechnol; 2007 Sep; 25(9):1051-6. PubMed ID: 17721510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Export of a heterologous cytochrome P450 (CYP105D1) in Escherichia coli is associated with periplasmic accumulation of uroporphyrin.
    Akhtar MK; Kaderbhai NN; Hopper DJ; Kelly SL; Kaderbhai MA
    J Biol Chem; 2003 Nov; 278(46):45555-62. PubMed ID: 12930844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engineered alkane-hydroxylating cytochrome P450(BM3) exhibiting nativelike catalytic properties.
    Fasan R; Chen MM; Crook NC; Arnold FH
    Angew Chem Int Ed Engl; 2007; 46(44):8414-8. PubMed ID: 17886313
    [No Abstract]   [Full Text] [Related]  

  • 29. New insights on the marine cytochrome P450 enzymes and their biotechnological importance.
    Sharifian S; Homaei A; Kamrani E; Etzerodt T; Patel S
    Int J Biol Macromol; 2020 Jan; 142():811-821. PubMed ID: 31622713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioconversion of small molecules by cytochrome P450 species expressed in Escherichia coli.
    Uno T; Okamoto S; Masuda S; Itoh A; Uno Y; Nakamura M; Kanamaru K; Yamagata H; Imaishi H
    Biotechnol Appl Biochem; 2008 Aug; 50(Pt 4):165-71. PubMed ID: 18052937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytochrome P450 monooxygenases: perspectives for synthetic application.
    Urlacher VB; Eiben S
    Trends Biotechnol; 2006 Jul; 24(7):324-30. PubMed ID: 16759725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequence-based screening for self-sufficient P450 monooxygenase from a metagenome library.
    Kim BS; Kim SY; Park J; Park W; Hwang KY; Yoon YJ; Oh WK; Kim BY; Ahn JS
    J Appl Microbiol; 2007 May; 102(5):1392-400. PubMed ID: 17448174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. P450(BM-3)-catalyzed whole-cell biotransformation of alpha-pinene with recombinant Escherichia coli in an aqueous-organic two-phase system.
    Schewe H; Holtmann D; Schrader J
    Appl Microbiol Biotechnol; 2009 Jul; 83(5):849-57. PubMed ID: 19266193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of new benanomicin analogues by biotransformation using Escherichia coli expressing actinomycete cytochrome P450.
    Kumagai H; Umekita M; Sawa R; Takahashi Y; Arisawa A; Isshiki K; Nishimura Y; Akamatsu Y
    J Antibiot (Tokyo); 2008 Jun; 61(6):394-9. PubMed ID: 18667788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Past and future applications of CYP450-genetic polymorphisms for biomonitoring of environmental toxicants.
    Yi B; Yang JY; Yang M
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(4):353-77. PubMed ID: 18000786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extending the diversity of cytochrome P450 enzymes by DNA family shuffling.
    Rosic NN; Huang W; Johnston WA; DeVoss JJ; Gillam EM
    Gene; 2007 Jun; 395(1-2):40-8. PubMed ID: 17400405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biotransformation enzymes as determinants of xenobiotic toxicity in domestic animals.
    Nebbia C
    Vet J; 2001 May; 161(3):238-52. PubMed ID: 11352482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficient terpene hydroxylation catalysts based upon P450 enzymes derived from actinomycetes.
    Celik A; Flitsch SL; Turner NJ
    Org Biomol Chem; 2005 Aug; 3(16):2930-4. PubMed ID: 16186924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions between human cytochrome P450 enzymes and steroids: physiological and pharmacological implications.
    Zhang YY; Yang L
    Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):621-9. PubMed ID: 19473111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetically-engineered mammalian cytochromes P-450 from yeasts--potential applications.
    Wiseman A
    Trends Biotechnol; 1993 Apr; 11(4):131-6. PubMed ID: 7763645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.